Delivery Order SPE2DB22D3301-SPE2DB25FX7VL

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $108K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $7,735.40 and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,727.12 firm fixed-price contract is for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of January 7, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a ceiling value of $11,539.30 and a period of performance through January 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,732.47, is for the supply of STELARA 90 MG/ML syringes, a specialty medication used in the treatment of various medical conditions. The contract has an ultimate completion date of May 30, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML syringes, which are a specialty medication. The contract has a ceiling value of $13,179.07 and an ultimate completion date of July 17, 2024. It is a firm-fixed-price contract, with no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,238.14 contract is for the supply of STELARA 90 MG/ML syringes, a specialty medication. The award has an ultimate completion date of October 24, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,930.20, is for the supply of STELARA 90 MG/ML syringes. It is a firm fixed-price contract with an ultimate completion date of August 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,207.68 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringes. The contract, valued at $13,857.59, has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to supply a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The contract has a firm fixed price of $71,539.42 and a completion date of January 9, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX7VL
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, with a ceiling value of $108,048.33, is for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/6/25, 12:42 AM